Liquidia Corp (LQDA)
9.90
-0.12
(-1.25%)
USD |
NASDAQ |
Nov 15, 14:37
Liquidia Cash and Short Term Investments (Quarterly): 133.09M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 133.09M |
| March 31, 2024 | 157.86M |
| December 31, 2023 | 83.68M |
| September 30, 2023 | 76.22M |
| June 30, 2023 | 88.20M |
| March 31, 2023 | 94.41M |
| December 31, 2022 | 93.28M |
| September 30, 2022 | 98.32M |
| June 30, 2022 | 103.84M |
| March 31, 2022 | 57.79M |
| December 31, 2021 | 57.49M |
| September 30, 2021 | 64.05M |
| June 30, 2021 | 67.89M |
| March 31, 2021 | 53.64M |
| Date | Value |
|---|---|
| December 31, 2020 | 65.32M |
| September 30, 2020 | 79.55M |
| June 30, 2020 | 23.59M |
| March 31, 2020 | 40.13M |
| December 31, 2019 | 55.80M |
| September 30, 2019 | 39.30M |
| June 30, 2019 | 52.12M |
| March 31, 2019 | 60.81M |
| December 31, 2018 | 39.54M |
| September 30, 2018 | 47.52M |
| June 30, 2018 | 9.232M |
| March 31, 2018 | 17.59M |
| December 31, 2017 | 3.419M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
23.59M
Minimum
Jun 2020
157.86M
Maximum
Mar 2024
78.64M
Average
76.22M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| United Therapeutics Corp | 3.326B |
| Arcturus Therapeutics Holdings Inc | 237.18M |
| Paragon 28 Inc | 46.74M |
| Tonix Pharmaceuticals Holding Corp | 4.156M |
| AIM ImmunoTech Inc | 10.06M |